X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RNAZ

Closed

Transcode Therapeutics Inc

7.5
-0.3 (-3.85%)
Last Update: 01 Jul 2025 23:00:00
Yesterday: 7.8
Day's Range: 7.405 - 7.99
Send
When Written:
 
0.3905
Transcode Therapeutics Inc. is a biopharmaceutical company that develops RNA-targeted therapeutics for the treatment of various diseases, including genetic disorders, cancer, and viral infections. The company's proprietary platform technology, called TRanslational Optimized RNA Therapeutics (TORT), enables the development of RNA-based drugs that can be delivered directly to target cells and tissues. Transcode's lead product candidate is TTX-MC138, a TORT-based therapy for the treatment of Huntington's disease. The company was founded in 2015 and is headquartered in San Diego, California.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.209
X